Genix Pharmaceuticals Corp
XTSX:GENX
Balance Sheet
Balance Sheet Decomposition
Genix Pharmaceuticals Corp
Genix Pharmaceuticals Corp
Balance Sheet
Genix Pharmaceuticals Corp
| Oct-2003 | Oct-2004 | Oct-2005 | Oct-2006 | Oct-2007 | Oct-2008 | Oct-2009 | Oct-2010 | Oct-2011 | Oct-2012 | Oct-2013 | Oct-2014 | Oct-2015 | Oct-2016 | Oct-2017 | Oct-2018 | Oct-2019 | Oct-2020 | Oct-2021 | Oct-2022 | Oct-2023 | Oct-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
4
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
1
+3%
|
1
+10%
|
0
-87%
|
0
+111%
|
0
+58%
|
0
-3%
|
0
-52%
|
0
+36%
|
1
+342%
|
1
-25%
|
1
+24%
|
1
-21%
|
0
-27%
|
0
-13%
|
0
-41%
|
0
-83%
|
5
+13 168%
|
5
-11%
|
4
-11%
|
0
-95%
|
0
-80%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+21%
|
0
-3%
|
0
-62%
|
0
+120%
|
0
-27%
|
0
+25%
|
0
-10%
|
0
+19%
|
0
-78%
|
0
-14%
|
0
+100%
|
0
-8%
|
0
-24%
|
0
+225%
|
0
-60%
|
0
-25%
|
0
+495%
|
1
+54%
|
1
+39%
|
1
+29%
|
1
-10%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
10
|
10
|
10
|
10
|
10
|
|
| Retained Earnings |
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
5
|
6
|
7
|
11
|
11
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
-19%
|
0
+36%
|
0
N/A
|
0
-133%
|
0
N/A
|
0
N/A
|
0
-1 200%
|
0
-8%
|
1
N/A
|
1
-25%
|
1
+16%
|
1
-23%
|
0
-27%
|
0
-67%
|
0
+1%
|
0
N/A
|
5
N/A
|
4
-17%
|
3
-20%
|
1
N/A
|
1
-4%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+3%
|
1
+10%
|
0
-87%
|
0
+111%
|
0
+58%
|
0
-3%
|
0
-52%
|
0
+36%
|
1
+342%
|
1
-25%
|
1
+24%
|
1
-21%
|
0
-27%
|
0
-13%
|
0
-41%
|
0
-83%
|
5
+13 168%
|
5
-11%
|
4
-11%
|
0
-95%
|
0
-80%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
19
|
19
|
19
|
19
|
19
|
22
|
22
|
22
|
22
|
32
|
32
|
32
|
38
|
38
|
38
|
38
|
38
|
59
|
59
|
59
|
59
|
59
|
|